Paul R Edick - GANIC Pharmaceuticals

Mr. Edick is the Chief Executive Officer of GANIC Pharmaceuticals, a start up specialty pharmaceutical company backed by the private equity firm Warburg Pincus, focused on enterprise development through acquisition of existing companies and products, as well as internal product development. Prior to starting GANIC, Mr. Edick was CEO of MedPointe Healthcare Inc., a position he has held since March of 2006. MedPointe Healthcare was a US based specialty pharmaceutical company located in Somerset New Jersey, USA. Mr. Edick negotiated the sale of MedPointe in 3Q 2007 to Meda AB, Sweden and separated in 1Q, 2008.

Mr. Edick has extensive industry experience from several leading pharmaceutical organizations. During the period April 2002 ? March 2006 Mr. Edick held the position as President of MedPointe Healthcare Inc. Between 1994-2002, in a series of positions at G. D. Searle and its acquirer, Pharmacia Corporation, he led Searle's US managed care organization (1994-95), its US marketing organization (1995-96), and its Global Pain & Inflammation Business including the development of the launch strategy for Celebrex® (1996-97). In 1998, Mr. Edick was named Searle's VP-Canada & Latin America. In 1999, Mr. Edick became President of Asia Pacific, Canada & Latin America. In 2000, upon Pharmacia's acquisition of Searle, Mr. Edick was named Group Vice President and President, Asia Pacific/Latin America at Pharmacia. Mr. Edick holds a B.A. in Psychology from Hamilton College, Clinton, New York, USA.

 

Tom Flynn – Ferrer Freeman & Co.

Tom Flynn is a Member of Ferrer Freeman & Company, LLC. He joined FFC in 1996. He was a Vice President in GE Capital's Equity Capital Group from 1993 to 1996 in the company's Stamford and London offices, the latter pursuant to a joint venture with Advent International. Prior to GE Capital, he held positions with Prudential Investment Corporation and Lehman Brothers Investment Banking division. Tom holds an A.B. degree from College of the Holy Cross and an M.B.A. degree from Harvard Business School. He currently serves on the Board of Directors of Aerocare Holdings, Inc., Genova Diagnostics, Informed Medical Communications, Inc. and PHNS, Inc. He is also an observer of the Board of MedPointe Pharmaceuticals.

 

Patrick Heron – Frazier Healthcare

Patrick Heron became a General Partner at Frazier Healthcare in 2005, having been a partner since 2001. Mr. Heron focuses on biotechnology and growth equity opportunities. Mr. Heron currently serves on the boards of Avera Pharmaceuticals, Chimerix, Genospectra, Informed Medical Communications, QuatRx Pharmaceuticals and Trubion Pharmaceuticals. Prior to joining Frazier Healthcare, Mr. Heron helped develop McKinsey & Co.'s West Coast biotechnology consulting practice after starting his career working with large pharmaceutical clients on the East Coast. His projects included corporate strategy, M&A, product launch, sales force optimization, corporate partnering and research prioritization. Prior to joining McKinsey, Mr. Heron also worked with Massachusetts General Hospital in evaluating spin-off opportunities and with Cetus Corporation. He was a Morehead Scholar at the University of North Carolina at Chapel Hill and holds an M.B.A. from Harvard Business School.

 

Thomas Patton, Chairman
Tom brings extensive experience in leading an array of private and public healthcare companies. Most recently, he was the CEO and founder of QDx, Inc., a diagnostic development company which explores new methods of hematology analysis. Prior to QDx, Inc., Tom was the President of Novametrix Medical Systems, Inc., a publicly traded worldwide leader in cardiopulmonary monitoring products for critical care patients. He has also served as the President and CEO of Wright Medical Technology, Inc., an orthopedic device company located in Memphis, TN. At Wright, Tom led a successful turnaround of the company, orchestrated its recapitalization led by a private equity firm and increased revenues to $140 million. Tom also served in various capacities at Wright Medical, including as General Counsel and EVP of Business Development. Tom started his career as a litigation attorney in Washington, D.C., after graduating from Georgetown Law School and Holy Cross College.

 

Charles T. Saldarini
Charles T. Saldarini is a successful, innovative entrepreneur credited with a leading role in the development of one of the healthcare service industry's leading markets?contract sales, approximately valued at $900 M?and one of its most respected service companies, PDI, a major player in the market for outsourced sales and marketing solutions sold to the biopharmaceutical industry. During his 18 year tenure with PDI, he led the company's development from a concept stage through to its maturity as a publicly traded company with annual revenues of approximately $365M. He retired from PDI in October, 2005.